Anti-Slamf6 antibodies are used in the immunodetection of the protein SLAM family member 6. In humans, the canonical protein has a reported length of 332 amino acid residues and a mass of 37.3 kDa. Its subcellular localization is in the cell membrane. Alternative splicing is reported to yield 3 different isoforms for this protein. It is noted to be expressed by all (resting and activated) natural killer cells (NK), T- and B-lymphocytes. SLAMF6 is reported to be a self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. Post-translational modifications have been described, including phosphorylation and glycosylation. Synonyms for this target antigen include NTBA receptor, activating NK receptor, natural killer-, T- and B-cell antigen, and NK-T-B-antigen.